Company intelligence / Profile preview
Deep Genomics
Toronto, Ontario, Canadadeepgenomics.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Preclinical
01
Overview
Deep Genomics has developed a proprietary AI-driven drug discovery platform focused on decoding complex RNA biology to identify novel therapeutic targets and design programmable RNA-based medicines. The company claims world-firsts in using AI to discover drug candidates—its lead program in Wilson disease was the first such example. As of mid–2025 it has at least ten preclinical programs targeting rare metabolic and neurological conditions with plans for rapid expansion; no human efficacy data reported yet but expects first-in-human studies imminently. The company collaborates with major pharma partners like BioMarin Pharmaceutical on rare-disease programs.
- Therapeutic areas
- Metabolic DisordersRare DiseasesNeurology
- Modalities
- RNA therapeutics (including antisense oligonucleotides)mRNA therapiesDNA editingRNA editing
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
BioMarin Pharmaceutical (collaboration on four rare-disease drug candidates)Mila – Quebec Artificial Intelligence Institute (academic research collaboration)
Beyond the preview
Go deeper on Deep Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Deep Genomics.